121 related articles for article (PubMed ID: 12386267)
1. A comparison between daily and thrice-weekly i.v. administration of 1,25-dihydroxy-22-oxavitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action in uraemic rats.
Hirata M; Endo K; Ohkawa H; Kumaki K; Kubodera N; Slatopolsky E; Kurokawa K; Fukagawa M
Nephrol Dial Transplant; 2002; 17 Suppl 10():37-40. PubMed ID: 12386267
[TBL] [Abstract][Full Text] [Related]
2. Effects of i.v. and oral 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in dogs with chronic renal failure.
Takahashi F; Furuichi T; Yorozu K; Kawata S; Kitamura H; Kubodera N; Slatopolsky E
Nephrol Dial Transplant; 2002; 17 Suppl 10():46-52. PubMed ID: 12386269
[TBL] [Abstract][Full Text] [Related]
3. A comparison between 1,25-dihydroxy-22-oxavitamin D(3) and 1,25-dihydroxyvitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action.
Hirata M; Endo K; Katsumata K; Ichikawa F; Kubodera N; Fukagawa M
Nephrol Dial Transplant; 2002; 17 Suppl 10():41-5. PubMed ID: 12386268
[TBL] [Abstract][Full Text] [Related]
4. Potent suppression of the parathyroid glands by hydroxylated metabolites of dihydrotachysterol(2).
Fan SL; Schroeder NJ; Calverley MJ; Burrin JM; Makin HL; Cunningham J
Nephrol Dial Transplant; 2000 Dec; 15(12):1943-9. PubMed ID: 11096138
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3.
Hirata M; Katsumata K; Endo K; Fukushima N; Ohkawa H; Fukagawa M
Nephrol Dial Transplant; 2003 Sep; 18(9):1770-6. PubMed ID: 12937223
[TBL] [Abstract][Full Text] [Related]
7. The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.
Brown AJ; Ritter CR; Finch JL; Morrissey J; Martin KJ; Murayama E; Nishii Y; Slatopolsky E
J Clin Invest; 1989 Sep; 84(3):728-32. PubMed ID: 2760211
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D analogues for secondary hyperparathyroidism.
Brown AJ; Dusso AS; Slatopolsky E
Nephrol Dial Transplant; 2002; 17 Suppl 10():10-9. PubMed ID: 12386264
[TBL] [Abstract][Full Text] [Related]
9. Abnormal calcaemic response to PTH in the uraemic rat without secondary hyperparathyroidism.
Berdud I; Martin-Malo A; Almaden Y; Tallon S; Concepcion MT; Torres A; Felsenfeld A; Aljama P; Rodriguez M
Nephrol Dial Transplant; 1996 Jul; 11(7):1292-8. PubMed ID: 8672025
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of 1,25-dihydroxy-22-oxavitamin D(3) on secondary hyperparathyroidism in haemodialysis patients. One-year administration study.
Akizawa T; Suzuki M; Akiba T; Nishizawa Y; Ohashi Y; Ogata E; Slatopolsky E; Kurokawa K
Nephrol Dial Transplant; 2002; 17 Suppl 10():28-36. PubMed ID: 12386266
[TBL] [Abstract][Full Text] [Related]
11. 22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.
Monier-Faugere MC; Geng Z; Friedler RM; Qi Q; Kubodera N; Slatopolsky E; Malluche HH
Kidney Int; 1999 Mar; 55(3):821-32. PubMed ID: 10027919
[TBL] [Abstract][Full Text] [Related]
12. Hyperphosphatemia modestly retards parathyroid hormone suppression during calcitriol-induced hypercalcemia in normal and azotemic rats.
Jara A; Chacón C; Felsenfeld AJ
Nephron; 2002 Dec; 92(4):883-8. PubMed ID: 12399635
[TBL] [Abstract][Full Text] [Related]
13. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
Soliman E; Canaff L; Fox J; Hendy GN
Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
[TBL] [Abstract][Full Text] [Related]
14. Effects of new vitamin D analogues on parathyroid function in chronically uraemic rats with secondary hyperparathyroidism.
Hruby M; Ureña P; Mannstadt M; Schmitt F; Lacour B; Drüeke TB
Nephrol Dial Transplant; 1996 Sep; 11(9):1781-6. PubMed ID: 8918622
[TBL] [Abstract][Full Text] [Related]
15. Multicenter clinical trial of 22-oxa-1,25-dihydroxyvitamin D3 for chronic dialysis patients.
Yasuda M; Akiba T; Nihei H
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S108-11. PubMed ID: 12612965
[TBL] [Abstract][Full Text] [Related]
16. How dietary phosphate, renal failure and calcitriol administration affect the serum calcium-phosphate relationship in the rat.
Jara A; Chacón C; Felsenfeld AJ
Nephrol Dial Transplant; 2002 May; 17(5):765-71. PubMed ID: 11981061
[TBL] [Abstract][Full Text] [Related]
17. Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: results of a preliminary study.
Kurokawa K; Akizawa T; Suzuki M; Akiba T; Ogata E; Slatopolsky E
Nephrol Dial Transplant; 1996; 11 Suppl 3():121-4. PubMed ID: 8840326
[TBL] [Abstract][Full Text] [Related]
18. Physiological doses of calcium regulatory hormones do not normalize bone cells in uraemic rats.
Szabó A; Freesmeyer MG; Abendroth K; Stein G; Rosivall L; El-Shakmak A; Ritz E
Eur J Clin Invest; 1999 Jun; 29(6):529-35. PubMed ID: 10354215
[TBL] [Abstract][Full Text] [Related]
19. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
[TBL] [Abstract][Full Text] [Related]
20. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Colecchia M; Leopardi O; Grossi L; Oldini C; Imbasciati E
Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]